Needham & Company LLC Cuts AtriCure (NASDAQ:ATRC) Price Target to $44.00
AtriCure (NASDAQ:ATRC – Free Report) had its target price lowered by Needham & Company LLC from $51.00 to $44.00 in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the medical device company’s stock. Other equities research analysts have also recently issued research reports about the stock. Piper […]
AtriCure (NASDAQ:ATRC – Free Report) had its target price lowered by Needham & Company LLC from $51.00 to $44.00 in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the medical device company’s stock. Other equities research analysts have also recently issued research reports about the stock. Piper […]
